Correlation Between International Business and Genscript Biotech
Can any of the company-specific risk be diversified away by investing in both International Business and Genscript Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining International Business and Genscript Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between International Business Machines and Genscript Biotech, you can compare the effects of market volatilities on International Business and Genscript Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in International Business with a short position of Genscript Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of International Business and Genscript Biotech.
Diversification Opportunities for International Business and Genscript Biotech
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between International and Genscript is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding International Business Machine and Genscript Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genscript Biotech and International Business is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on International Business Machines are associated (or correlated) with Genscript Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genscript Biotech has no effect on the direction of International Business i.e., International Business and Genscript Biotech go up and down completely randomly.
Pair Corralation between International Business and Genscript Biotech
Considering the 90-day investment horizon International Business Machines is expected to under-perform the Genscript Biotech. But the stock apears to be less risky and, when comparing its historical volatility, International Business Machines is 3.0 times less risky than Genscript Biotech. The stock trades about -0.24 of its potential returns per unit of risk. The Genscript Biotech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 126.00 in Genscript Biotech on October 7, 2024 and sell it today you would earn a total of 1.00 from holding Genscript Biotech or generate 0.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 95.24% |
Values | Daily Returns |
International Business Machine vs. Genscript Biotech
Performance |
Timeline |
International Business |
Genscript Biotech |
International Business and Genscript Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with International Business and Genscript Biotech
The main advantage of trading using opposite International Business and Genscript Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if International Business position performs unexpectedly, Genscript Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genscript Biotech will offset losses from the drop in Genscript Biotech's long position.International Business vs. EPAM Systems | International Business vs. Infosys Ltd ADR | International Business vs. Cognizant Technology Solutions | International Business vs. Fiserv Inc |
Genscript Biotech vs. Novo Nordisk AS | Genscript Biotech vs. Novo Nordisk AS | Genscript Biotech vs. Vertex Pharmaceuticals | Genscript Biotech vs. CSL |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |